Chariot J, Appia F, Vaille C, Rozé C
INSERM U239, Faculté X. Bichat, Paris, France.
Fundam Clin Pharmacol. 1987;1(4):243-52. doi: 10.1111/j.1472-8206.1987.tb00563.x.
The effects of modafinil and adrafinil, 2 drugs that induce locomotor hyperactivity, and those of the parent compounds CRL 40467 and CRL 40385, were studied on the external pancreatic secretion of anaesthetized and conscious rats. In anaesthetized rats modafinil, adrafinil, and CRL 40385 antagonized the central vagal stimulation of protein output induced by 2-deoxy-D-glucose in the pancreatic juice. In conscious rats, modafinil and adrafinil inhibited the output of protein in the basal interdigestive pancreatic secretion. Modafinil was more active than adrafinil as an inhibitor of pancreatic secretion. The effects of modafinil and adrafinil were different from those of sympathetic amines and dopamine: they did not stimulate the output of bicarbonate in anaesthetized rats, and pancreatic inhibition observed in conscious rats was not inhibited by either yohimbine or prazosin.
研究了莫达非尼和阿屈非尼这两种能诱发运动性多动的药物以及母体化合物CRL 40467和CRL 40385对麻醉和清醒大鼠胰腺外分泌的影响。在麻醉大鼠中,莫达非尼、阿屈非尼和CRL 40385拮抗了2-脱氧-D-葡萄糖诱导的胰腺汁中蛋白质输出的中枢迷走神经刺激。在清醒大鼠中,莫达非尼和阿屈非尼抑制了基础消化间期胰腺分泌中的蛋白质输出。作为胰腺分泌抑制剂,莫达非尼比阿屈非尼更具活性。莫达非尼和阿屈非尼的作用不同于交感胺和多巴胺:它们不会刺激麻醉大鼠中碳酸氢盐的输出,并且清醒大鼠中观察到的胰腺抑制不受育亨宾或哌唑嗪的抑制。